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ABSTRACT   
Manganese (Mn) is a required co-factor for many ubiquitous enzymes; however, 
chronic manganese overexposure can cause manganism, a parkinsonian-like 
syndrome. Previous studies showed manganese influx into brain is carrier-mediated, 
though the putative carrier(s) were not established. Studies conducted with cultured 
bovine brain microvascular endothelial cells (bBMECs), which comprise the blood-
brain barrier, revealed 54Mn (II) uptake positively correlated with pH, was 
temperature-dependent, and was sodium- and energy-independent. Brain 54Mn 
uptake correlated inversely with calcium (Ca) concentration, but 45Ca uptake was 
unaltered by high Mn concentration. Lanthanum (La), a non-selective inhibitor of 
several Ca channel types, as well as verapamil and amiloride, inhibitors of voltage-
operated Ca channels, failed to inhibit Mn uptake into cells. Nickel (Ni), another non-
selective inhibitor of several Ca channel types, inhibited Mn and Ca uptake into cells 
by 88 and 85 %, respectively. Cyclopiazonic acid (CPA) and thapsigargin, which 
activate store-operated calcium channels (SOCCs), increased 54Mn and 45Ca uptake 
into cultured bBMECs. In situ brain perfusion studies were conducted in adult, male 
Sprague-Dawley rats to verify the cell culture results. Both nickel and verapamil 
produced a non-significant decrease in Mn and Ca influx. Lanthanum significantly 
increased Mn influx to 675 and 450 % of control in parietal cortex and caudate, 
respectively, while producing no significant effect on Ca influx. Vanadate, which 
inhibits Ca-ATPase, inhibited Mne uptake into cultured blood-brain barrier cells, but 
not into perfused rat brain. Overall these results suggest that both Ca-dependent 
and Ca-independent mechanisms play a role in brain Mn influx. This work provides 
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evidence that store-operated Ca channels, as well as another blood-brain barrier 
transporter, are likely to mediate carrier-mediated Mn influx into the brain. 
 
Running title:  Mn brain influx at the BBB through SOCs 
 
Key words/phrases: manganese, blood-brain barrier, influx, store-operated calcium 
channel 
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INTRODUCTION 
The trace element manganese (Mn) is essential for normal brain development and 
function throughout the life span of all mammals (Keen et al., 2000). Mn is a co-
factor for many enzymes, including the brain-specific enzyme glutamine synthetase 
(Wedler and Denman, 1984) and ubiquitously expressed enzymes including 
superoxide dismutase 2 and pyruvate carboxylase (Keen, et al., 2000). While Mn is 
essential for normal brain function, excess brain Mn is neurotoxic and can produce 
manganism, a parkinsonian-like syndrome (Hudnell, 1999; Iregren, 1999). 
Neurotoxicity due to excess Mn has been reported following occupational inhalation 
exposure to Mn in mining operations (Couper, 1837), in dry-cell battery production 
(Keen and Lönnerdal, 1995), in ferromanganese smelting (Huang et al., 1989) and 
during Mn welding operations (Chandra et al., 1981; Ono et al., 2002); following non-
occupational exposure to inhaled Mn (Hudnell, 1999) and following intestinal 
exposure of Mn in drinking water. There is currently significant concern about airborne 
Mn exposure from the fuel additive methylcyclopentadienyl manganese tricarbonyl 
(MMT) (Hudnell, 1999). Current treatments for patients with manganism may 
postpone the progression of symptoms, but have not been able to cure the disease 
(reviewed in (Lee, 2000). 
 
As the general public’s Mn exposure increases with increased MMT use, the 
mechanisms of Mn homeostasis become more important in understanding and 
assessing the risk of neurotoxicity. Mn brain entry from blood can occur through the 
capillary endothelial cells of the blood-brain barrier (BBB) and through the choroid 
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plexuses. Several studies suggested that Mn ion brain influx at the BBB is carrier-
mediated (Aschner and Aschner, 1990; Murphy et al., 1991; Rabin et al., 1993; 
Aschner and Gannon, 1994; Crossgrove et al., 2003). Similarly, Mn appears to be 
actively transported into bile, achieving a concentration gradient as high as 100-fold 
(Klaassen, 1974). The identity of the Mn carrier(s) is unknown. Mn efflux across the 
BBB does not appear to occur through a carrier but rather by diffusion (Yokel et al., 
2003). Several studies suggested that the divalent metal transporter-1 (DMT-1) may 
be responsible for Mn ion influx into brain (Goddard et al., 1997; Gunshin et al., 
1997; Conrad et al., 2000), but a recent report suggests that the lack of functional 
DMT-1 in rats has no effect on brain influx of the Mn ion or the Mn-transferrin 
complex (Crossgrove and Yokel, 2004). 
 
The current work examined whether brain Mn influx at the BBB is mediated by one 
or more calcium (Ca) transport pathways. Ca inhibited Mn entry into Hep-G2 cells 
(Finley, 1998). Cell Mn entry across cell membranes was decreased by Ca inhibitors 
(Mason et al., 1993) and increased by activators of Ca influx (Kerper and Hinkle, 
1997a). Mn entry through store-operated Ca channels (SOCs) has been 
demonstrated in rat mast and osteoblast-like cells and human platelets (Fasolato et 
al., 1993; Dobrydneva and Blackmore, 2001; Baldi et al., 2002). Others have 
reported evidence of SOCs on brain endothelial cells (Kerper and Hinkle, 1997b; 
Kim et al., 2004). In this work, we examined the mechanism(s) of Mn brain entry 
across the BBB. We first examined general characteristics of Mn uptake at the BBB 
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and then tested the hypothesis that Mn influx at the BBB occurs through one or more 
Ca influx processes.   
 
MATERIALS AND METHODS 
Materials 
54MnCl2 (specific activity 107 or 38 nCi/ng; total Mn 184 or 477 nM) in 0.5 M HCl was 
purchased from Perkin-Elmer/NEN (Boston, MA). 45CaCl2 (5.87 nCi/ng) in water was 
purchased from Perkin-Elmer/NEN. [14C]sucrose was purchased dry from Perkin-
Elmer/NEN (3.6 nCi/nmol) and in 2% ethanol from Moravek (Brea, CA; 495 
nCi/nmol) or American Radiolabeled Chemicals, Inc. (620 nCi/nmol). All other 
chemicals were purchased from Sigma (St. Louis, MO) unless otherwise noted. 
Sprague-Dawley rats (225-300 g) were purchased from Harlan (Indianapolis, IN).  
Verapamil was solubilized in methanol, diluted and delivered in 0.2% methanol.  
Thapsigargin was solubilized by DMSO and cyclopiazonic acid by methanol and 
delivered in 0.1% DMSO or methanol. Vehicle controls contained equimolar solvent. 
All animal research was conducted under the guidelines of the Guide for the Care 
and Use of Laboratory Animals and with the approval of the University of Kentucky 
Institutional Animal Care and Use Committee. 
 
Isolation of bovine brain microvascular endothelial cells (bBMECs) 
The bBMECs were isolated from fresh bovine brains, as described (Bowman et al., 
1983; Audus et al., 1996). Cells were grown in 35 mm plastic dishes at 37°C in 5% 
CO2 with nutrient media containing 10% horse serum in 50% MEM and 50% Ham’s 
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F-12 supplemented with NaHCO3 (13 mM), HEPES (10 mM) penicillin G (100 U/mL) 
and streptomycin (100 µg/ml). Cell identity was verified by the presence of the 
following characteristics of bBMECs. 1.) They were positive for γ-
glutamyltransferase and alkaline phosphatase activity. 2.) They did not have the 
processes or shapes of neurons or glial cells according to morphologic analysis of 
TEM images. 3.) They took up histidine (Yamakami et al., 1998).   
 
Studies of 54Mn uptake conducted in bBMECs  
54Mn uptake was determined in 85-90% confluent cell cultures following procedures 
established for another BBB cell line (Yokel et al., 2002). In summary, each cell-
containing culture dish was rinsed three times with a wash solution containing (in 
mM): Na+ 122, K+ 4.2, Ca2+ 1.5, Mg2+ 0.9, Cl- 131, HEPES 10, and D-glucose 10 at 
pH 7.4 and at the temperature of the uptake experiment. The last wash remained in 
the dish at least 10 minutes to bring the cells to the temperature of the uptake 
experiment. The cells were incubated with 0.75 mL uptake solution consisting of 
wash solution containing 54Mn2+ (~1 µCi/mL) and [14C]-sucrose (1 µCi/mL; 0.2 µM) in 
the presence or absence of treatment. After 10 to 120 minutes the uptake solution 
was removed and the cells rapidly washed 5 times with ice-cold wash solution. Cells 
were solubilized in 1 M sodium hydroxide for 15 min at room temperature then 
neutralized with equimolar HCl. Aliquots of cell lysates were collected for analysis of 
radioactivity and total protein content.   
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Cell viability was measured in parallel dishes of cultured bBMECs exposed to the 
same treatments in the absence of the radionuclides. Cell membrane integrity was 
measured by determining the activity of the cytosolic enzyme lactate dehydrogenase 
(LDH) released into the uptake media. LDH activity was measured with an assay kit 
(Sigma). Cell redox potential, an indicator of cell health, was measured by 
methylthiazoletetrazolium (MTT) conversion to its formazan product. When MTT 
conversion was less than 80% of control the cells were considered to have 
drastically changed. Data from these cells were not used (except in studies of 
metabolic inhibitors and low temperature). 
 
bBMECs were selected as a model of the BBB to screen characteristics of Mn uptake, 
with the intent of following significant findings in the intact rat. Initially, Mn uptake into 
bBMECs was measured from 10-120 minutes at pH 6.4 and 7.4 to determine 
whether it was linear, as several pHs were used in subsequent studies. 54Mn2+ 
uptake over 30 minutes was measured in media buffered to pH 5.4, 6.4, 6.9, 7.4 and 
7.9 by 10 mM potassium hydrogen phthalate (pH 5.4), PIPES (pH 6.4), MOPS (pH 
6.9), or HEPES (pH 7.4 and 7.9). Mn uptake was also measured during a 30 minute 
incubation at 4 (on ice), 8, 21, 30 and 37°C; at 37°C in the presence of a metabolic 
inhibitor, 2,4-dinitrophenol (0.25 mM) or azide (10 mM); and with the replacement of 
glucose (10 mM) by 2-deoxyglucose (10 mM). The role of sodium in Mn uptake was 
measured by replacing 50 or 100% of the sodium in the uptake media with choline or 
lithium or by the addition of ouabain (0.1 mM). The role of Ca transporters in Mn 
uptake was examined by changing Ca concentration from 0 to 1.5 mM; by addition 
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of Ca transporter inhibitors including vanadate (0, 0.003, or 1 mM), lanthanum (La3+; 
0.050 mM as La(NO3)3), nickel (Ni; 1 mM as NiCl2) or verapamil (0.3 mM); or by 
addition of the Ca transporter activators cyclopiazonic acid (CPA; 0.01 mM) and 
thapsigargin (0.001 mM). 
 
In situ brain perfusion studies 
Rats were prepared and perfused as described previously (Crossgrove, et al., 2003). 
Briefly, a cannula containing heparinized saline was inserted into the right common 
carotid artery. The open end was transferred to a syringe containing a perfusate with 
the treatment and/or radioisotope tracers. Perfusate delivery was regulated by a 
syringe pump. Immediately before brain perfusion began, the rat’s cardiac ventricles 
were severed to avoid mixing of blood with perfusate. The perfusion (45, 90 or 180 
s) was terminated by decapitation. The brain was extracted and the ipsilateral 
parietal cortex, caudate and lateral ventricular choroid plexus removed, weighed and 
assayed for radioactivity. In some experiments, the cerebrum was homogenized 
according to the capillary depletion method as described (Crossgrove, et al., 2003). 
 
The perfusate contained 1 to 2 µCi 54Mn2+/ml and a marker for vascular and 
extracellular space, 14C-sucrose (1 µCi/ml), in a solution containing (in mM): Na+ 
122, K+ 4.2, Ca2+ 1.5, Mg2+ 0.9, Cl- 131, glucose 10, and HEPES 10. To test the 
hypothesis that Mn and Ca share one or more transporters, rats were treated with 
perfusates containing 54Mn2+ and 0 added, 1.5 (control) or 9 mM Ca or 45Ca and Mn 
(0 or 15 mM). Other experiments included the Ca transporter inhibitors sodium 
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vanadate (1 or 10 mM), p-hydroxyhippuric acid (0.4 mM), verapamil (0.3 mM) or 
amiloride (0.84 mM) to determine whether Ca transporters play a role in rat brain Mn 
influx. 
 
Radioactivity and total protein determination 
Radioactivity of 54Mn and 14C were determined in aliquots of cell lysate or in digested 
tissue as described (Crossgrove, et al., 2003). Radioactivity from 45Ca was counted 
from 156-257 keV by a liquid scintillation counter, with appropriate corrections for 
crossover, quench and decreased efficiency due to the narrowed counting window. 
Protein concentration in cell lysates was measured via the bicinchoninic acid method 
with a kit (Sigma). 
 
Data and statistical analysis 
In bBMEC experiments, 54Mn, 45Ca and 14C activities (dpm/dish) and total protein 
(mg/dish) were calculated. 54Mn, 45Ca and [14C]-sucrose uptake values were 
converted to dpm/mg protein. Non-specific binding to cell and collagen surfaces was 
determined by apparent uptake in 15 s on ice. Collagen was found to sequester Mn, 
but not 14C or 45Ca, during the time course of these experiments.  Estimated 
confluence was used to predict the surface area of the collagen-coated dish that was 
exposed to 54Mn uptake media. Uptake into collagen was determined as: 
 
Mn uptake into collagen = (100%-confluence%)*(uptake into collagen-only dish)   
 
 BBB Mn influx through SOCs 11 
Nonspecific Mn adsorption to the dish was also determined several times. It was 
negligible. Non-specific binding and estimated binding to collagen were subtracted 
from total uptake to obtain corrected values for 54Mn, 45Ca, and 14C uptake into cells. 
These corrected values (dpm/mg protein) were divided by the activity of the uptake 
solution (dpm/ml) to obtain a volume of distribution of uptake (ml/mg protein) from 
uptake media.     
 
The [14C]-sucrose volume represents diffusional and pinocytotic uptake processes. 
This value was subtracted from the 54Mn and 45Ca volumes of distribution to 
generate a term expressing Mn or Ca uptake into the cells via carrier(s). Mn uptake 
(ml/mg protein) was converted to pmol Mn/mg protein by multiplying by total Mn 
concentration. Intracellular Mn concentration was then estimated from the 
relationship of 2 µl intracellular space per mg total protein (Edlund and Halestrap, 
1988; Poole et al., 1989).   
 
In perfusion experiments, radioactivity (dpm/g tissue) was divided by perfusate 
activity (dpm/ml) to calculate the volume of distribution (ml/g). This was divided by 
the perfusion duration (45 to 90 s) to obtain the influx transfer coefficient (Kin), as 
described in detail (Crossgrove, et al., 2003). All bBMEC experiments were 
completed with at least three replicates per experiment, each conducted in duplicate 
or triplicate. Results of the time course of Mn uptake at pH 6.4 and 7.4 were 
analyzed by regression analysis using GraphPad Prism to determine if uptake was 
best fit by a first or second order relationship. Uptake in the presence of treatments 
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was converted to a percent of control uptake for each experiment. The mean and 
relative standard deviation were calculated.  For cell and perfusion experiments, t-
tests or one-way ANOVAs were conducted using GraphPad Prism to test for 
treatment differences. When treatment differences were found, post-hoc 
comparisons by Dunnett’s or Bonferroni’s tests were conducted after the ANOVAs to 
determine significant differences among treatment groups.   
 
For all studies, p < 0.05 was accepted as statistically significant. 
 
RESULTS 
54Mn uptake into bBMECs was initially studied up to 120 minutes to assess linearity 
during that time (Figure 1 Inset). Regression analysis showed Mn uptake results 
obtained at pH 7.4 and 6.4 were better fit by linear than non-linear regression. The 
95% confidence intervals for the slopes excluded one another. Mn2+ uptake at pH 
6.4 was significantly less than at 7.4. For the remaining studies, 30-minute uptake 
was used as representative. 
  
At the 120 minute time point, the intracellular Mn concentration (overall means of 
10.6 and 3.4 µM for pH 7.4 and 6.4, respectively), exceeded the media Mn 
concentration (184 nM) by at least 10 fold. In later experiments using 54Mn at a lower 
specific activity and higher total Mn (477 vs. 184 nM), the intracellular concentration 
at 30 minutes was at least 3-fold, and usually 10-fold, greater than the extracellular 
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concentration. Intracellular Mn concentration was higher than extracellular Mn 
concentration in all experiments under control conditions.  
 
Mn uptake was inversely related to proton concentration. This was noted in the time 
course of Mn uptake conducted at pH 6.4 and 7.4 as well as the uptake study 
conducted at pH 5.4, 6.4, 6.9, 7.4 and 7.9 (Figure 1). The results from cells treated 
at pH 5.4 for 30 minutes are not shown because they produced only 6% of the 
formazan product/mg protein that was found in control (pH 7.4) cells, indicating 
severe cell toxicity.   
 
Temperature-dependence of uptake 
Mn uptake into bBMECs was measured at five temperatures. The data were 
graphed as an Arrhenius plot of natural log of the uptake rate versus inverse of 
absolute temperature (Figure 2). The plot appears to have a change in slope (a 
breakpoint); however, the data are not significantly non-linear. Rearrangement of the 
Arrhenius equation, as follows, generated the activation energy (Ea). 
 
  Ea = -R * (d ln k)/d (1/T) 
 
where R is the ideal gas constant, k is the uptake rate and d(ln k)/d(1/T) is the slope 
of Figure 2. Ea was determined to be 27 kJ/mol.   
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Sodium- and energy-independence of uptake 
Mn uptake into bBMECs was not inhibited by replacement of the sodium in the 
uptake medium (Table 1). Sodium replacement by choline resulted in a significant 
increase of Mn uptake into bBMECs. Energy production inhibitors reduced MTT 
conversion to formazan by ~ 40% (results not shown) but did not significantly affect 
Mn uptake into bBMECs (Table 1).  
 
Calcium-dependence of bBMEC uptake and brain influx   
There was an inverse relationship between Ca concentration and brain Mn influx 
(Figure 3) as well as Mn uptake and Ca concentration in bBMECs (Table 2). 
However, Mn did not inhibit brain Ca influx (Figure 3).   
 
La3+ increased brain Mn influx (Figure 4), and Ni did not decrease Mn influx into rat 
brain (Figure 5).  Verapamil did not significantly inhibit Mn influx compared to control.   
Mean Mn influx values ± SEM (n=5-6) for control versus verapamil were 20.6 ± 2.7 
vs. 14.9 ± 1.6; 12.4 ± 2.5 vs. 6.6 ± 0.4; and 1218 ± 108 vs. 863 ± 62 x 10-5 ml/s/g for 
parietal cortex, caudate or choroid plexus, respectively. Another voltage-gated Ca 
channel inhibitor, amiloride, did not inhibit brain Mn influx (Ca was not tested). Mn 
influx values for control versus amiloride-treated brains were 6.2 ± 2.2 vs. 11.3 ± 5.7; 
6.7 ± 0.7 vs. 4.7 ± 1.6; 2197 ± 421 vs. 1756 ± 178 x 10-5 ml/s/g for the parietal 
cortex, caudate or choroid plexus, respectively (mean ± SEM of 4 control and 3 
treated brains). 
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Brain Ca influx was measured concurrently with Mn influx for control perfusates and 
those with La, Ni or verapamil.  Control Ca influx values (mean ± SEM, n=5-6) were 
85.1 ± 15.7, 61.4 ± 11 and 873 ± 177 x 10-5 ml/s/g for parietal cortex, caudate and 
choroid plexus, respectively. Ca influxes with La were 75 ± 22.9, 55.1 ± 27.2 and 
672 ± 145 x 10-5 ml/s/g.  Ca influx with Ni were 62.1 ± 18.5; 39.6 ± 10; and 1058 ± 
497 x 10-5 ml/s/g for parietal cortex, caudate and choroid plexus, respectively; with 
verapamil, 80.4 ± 10.5; 54.7 ± 7.5; and 922 ± 182 x 10-5 ml/s/g.  Brain Ca influx was 
not significantly affected by any of these treatments within this short time course. 
 
La3+ decreased Ca uptake into bBMECs without having a significant effect on Mn 
uptake (Table 2).  Ni significantly inhibited Ca and Mn uptake into bBMECs (Table 
2).  In addition to its effect on brain influx, verapamil also produced parallel, non-
significant decreases of Mn and Ca uptake into bBMECs (Table 2).  
 
Vanadate (1 mM) did not significantly inhibit Mn influx into the tested brain regions or 
the choroid plexus following its co-perfusion with 54Mn2+ for 90 seconds. Mean 
values ± SEM (4 rats per group) were 49.2 ± 21.1 vs. 51.2 ± 23.8, 7.4 ± 2.8 vs. 17.0 
± 10.5 and 759 ± 347 vs. 450 ± 190 x 10-5 ml/s/g for control vs. vanadate-treated 
parietal cortex, caudate and choroid plexus tissues. When the brain was perfused 
with 1 mM vanadate for 90 s and then immediately switched to a co-perfusion of 
vanadate with 54Mn2+, Mn influx was not inhibited by the vanadate pre-wash 
exposure. The control and vanadate-treated brain Mn influx values were 4.4 ± 0.9 
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vs. 16.4 ± 7.7, 2.6 ± 0.7 vs. 4.0 ± 0.7 and 247 ± 35 vs. 746 ± 53 x 10-5 ml/s/g for the 
parietal cortex, caudate and choroid plexus regions of the brain, respectively (mean 
± SEM for 6 rats per group). A higher concentration of vanadate (10 mM) also failed 
to inhibit brain Mn influx. The parietal cortex, caudate and choroid plexus Mn influx 
values were 13.4 ± 4.4 vs. 21.5 ± 6.6, 7.4 ± 1.6 vs. 11.4 ± 4.1 and 1063 ± 294 vs. 
1376 ± 318 x 10-5 ml/s/g brain for control vs. vanadate-treated brain, respectively 
(mean ± SEM for 5 rats per group). Vanadate did not change the distribution of Mn 
in the endothelial cells or the brain parenchyma. Endothelial cells retained 10 and 
13% of the total Mn entering brain following perfusion with Mn or Mn with vanadate 
(10 mM; data not shown). Therefore, brain parenchyma contained 90 and 87% of 
the Mn that had crossed the BBB.   
 
Contrary to in situ perfusion results, addition of 3 µM or 1 mM vanadate inhibited Mn 
uptake into bBMECs (Table 2). Furthermore, this effect persisted after vanadate was 
washed out. Cells treated 30 minutes with 1 mM vanadate, washed twice and 
incubated with vanadate-free uptake media had only 39% of control Mn uptake 
(Table 2).   
 
Addition of p-hydroxyhippuric acid (0.4 mM) to the brain perfusate did not inhibit 
brain Mn influx (Ca influx was not tested). The control and experimental brain Mn 
influx values were 7.4 ± 0.6 vs. 12.7 ± 1.8, 8.6 ± 1.4 vs. 6.7 ± 0.6 and 1375 ± 100 vs. 
1310 ± 122 x 10-5 ml/s/g for the parietal cortex, caudate and choroid plexus, 
respectively (mean ± SEM for 6 control and 7 treated rats). In the cerebellum only, 
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there was a non-significant trend for a p-hydroxyhippuric acid-induced decrease of 
Mn influx (11.0 ± 1.9 vs. 5.7 ± 0.6 x 10-5 ml/s/g for control vs. p-hydroxyhippurate).   
 
Studies with modulators of store-operated Ca channels 
CPA significantly increased Mn and Ca uptake when studied concurrently (Table 2). 
Ca uptake following thapsigargin treatment was not significantly greater than control 
(P=0.07), although Ca uptake in thapsigargin-treated cells was 1.4-10 fold greater 
than in control cells in each experimental replicate. Mn uptake was significantly 
greater in thapsigargin-treated than in control cells (Table 2).   
 
DISCUSSION 
This research examined the mechanism of carrier-mediated Mn entry into the rat 
brain across the BBB. The first objective was to determine general characteristics of 
carrier-mediated Mn uptake. The second objective tested the hypothesis that brain 
Mn entry was mediated by one or more Ca transporters. The results suggest that 
brain Mn influx occurs through at least one pathway which is not Ca-mediated as 
well as one or more pathways involving SOCs. 
 
Our results are consistent with previous reports of carrier-mediated Mn uptake at the 
BBB (Aschner and Aschner, 1990; Murphy, et al., 1991; Rabin, et al., 1993; Aschner 
and Gannon, 1994; Crossgrove, et al., 2003). Here, we report concentrative Mn 
uptake, providing evidence of a carrier-mediated process. The temperature-
dependence study suggests that the activation energy of this process is 27 kJ/mol, 
consistent with values reported for ion channels (18-34 kJ/mol) by 
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electrophysiological techniques (Liu et al, 1996). This supports the suggestion that 
brain Mn uptake occurs through one or more carrier-mediated processes. Finally, 
the negative correlation between proton concentration and Mn uptake into bBMECs 
agrees with our report that Mn uptake is not likely to occur through the divalent metal 
transporter-1, which co-transports a proton with a divalent metal ion (Crossgrove 
and Yokel, 2004).  
 
Brain Mn uptake was not inhibited by 2,4-dinitrophenol, azide or 2-deoxyglucose, 
suggesting it is not directly dependent on an energy source mediated by ATP 
hydrolysis. Nor was brain Mn uptake inhibited by ouabain, showing it to be 
independent of Na+/K+-ATPase. While these studies did not provide evidence for 
energy dependence, the concentrative uptake seen in the bBMEC studies must rely 
on an energy source or electron transfer. The conversion of MTT to formazan in 
treated cells was ~60% of control cells, suggesting reduction, but not elimination, of 
cell redox potential when ATP-inhibitors were present. Therefore, the lack of effect 
by metabolic inhibitors may be due either to the lack of an ATP-dependent Mn 
transporter or to the ability of the ATP-dependent Mn transporter(s) to continue at 
their normal rate when ATP is reduced to 60%. Alternatively, the pH dependence 
suggests that there might be an electromotive driving force maintaining Mn uptake. 
However, the positive correlation between Mn uptake and pH suggest that it is not 
an inward proton or cation electromotive force. This suggests that the Mn transporter 
may be a proton or cation antiporter.   
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Brain Mn uptake was sodium-independent, suggesting the uptake carrier(s) do not 
utilize a sodium gradient as a driving force. Replacing sodium with choline increased 
brain Mn uptake. One report provides evidence that Mn inhibits choline uptake at the 
BBB (Lockman et al., 2001). The authors suggested that the choline transporter may 
be involved in brain Mn uptake, though they did not test the effect of choline on Mn 
uptake. Choline uptake into rat brain, like Mn uptake, has been described to be 
sodium-independent (Allen and Smith, 2001). Mn and choline may share one or 
more transport process(es). On the other hand, choline increased Mn uptake, which 
would not be expected if they were competing for an uptake process. While the 
basis of any interaction between Mn and choline is unclear, it is clear that Mn uptake 
at the BBB is sodium independent.  
 
Ca appears to play a significant role in Mn influx at the BBB. When Ca was not 
added to the perfusate, Mn influx was significantly greater than in the presence of 
normal (1.5 mM) Ca. Brain Mn influx was slightly, but not significantly, less in the 
presence of 9 mM Ca. Ca has been shown to inhibit Mn uptake into astrocytes in 
competitive and non-competitive manners (Aschner et al., 1992). Mn uptake into 
bBMECs also increased in the absence of added Ca compared to uptake media with 
normal (1.5 mM) Ca. Overall, Ca concentration correlates negatively with Mn influx. 
This concentration-dependent effect does not distinguish whether Ca and Mn 
directly compete for the same carrier or whether Ca indirectly modulates Mn uptake. 
On the other hand, added Mn did not inhibit 45Ca influx into rat brain compared to 
control (no added Mn) perfusate (Figure 3), suggesting Mn and Ca do not compete 
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for the same carrier, or that the capacity of any common carrier(s) is very large. 
Depending on the affinity of the Ca carrier for Mn, the 10-fold greater concentration 
of Mn above that of Ca used in the present studies may not be sufficient to inhibit 
brain Ca influx. A 6-fold increase in Ca failed to significantly inhibit Mn influx, which 
suggests either that they have separate carriers or that their shared pathway(s) has 
a great substrate capacity.   
 
Mn uptake into bBMECs was inhibited by Ni, consistent with a role for Ca channels 
in Mn uptake. Ni has been shown to inhibit receptor-operated Ca channels and 
store-operated channels (Cui and Dannies, 1992; Kukkonen et al., 2001). Ni is 
thought to be a rather specific inhibitor of Ca channels, as it did not appear to be a 
substrate for the channels it blocks (Shibuya and Douglas, 1992; Jones and Sharpe, 
1994). In the current study, Ni blocked Mn uptake (to 12% control) in bBMECs in a 
manner parallel to its effect on Ca uptake (15% control), providing strong evidence 
that Mn uptake may occur through Ca uptake pathways. An alternative explanation 
is that Ni blocks equally two or more separate pathways for Mn and Ca uptake, 
rather than our suggestion of a common pathway. In perfusion studies, Ni failed to 
block Mn and Ca brain influx. The difference between the animal and bBMEC 
studies may be due to the shorter experimental duration of in situ brain perfusion (90 
s) than bBMEC studies (30 min). The lack of brain Mn influx inhibition by Ni may be 
due to Ni’s inability to block Ca influx. The animal data, therefore, do not reveal any 
information whether Mn and Ca share the same BBB carrier(s) that are inhibited by 
Ni.   
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Ni significantly inhibited choroid plexus Mn influx; however, it did not inhibit Ca influx 
into the choroid plexus. This suggests that Mn and Ca may have separate uptake 
mechanisms at this blood-cerebrospinal fluid interface. The choroid plexus is 
believed to be the main site of Ca influx into brain. If the choroid plexus is vital in 
maintaining Ca homeostasis as implicated (Murphy et al., 1989; Keep et al., 1999), 
then perhaps the carriers expressed at the choroid plexus have a stronger affinity for 
Ca, rendering the Ni treatment an ineffective inhibitor of Ca influx. Alternatively, Ni 
may not have had sufficient time to inhibit Ca transporters, or the inhibition of Mn 
uptake into choroid plexus is independent of Ca transporters.        
 
The results with the Ca transporter blocker, La3+, suggest that a non-Ca pathway 
also mediates brain Mn influx. La3+ inhibition of Ca uptake has been shown in 
voltage-gated Ca channels, receptor-operated Ca channels and store-operated Ca 
channels (Cui and Dannies, 1992; Davidson and Guo, 2000; Liu and Ambudkar, 
2001; Wu et al., 2001). In perfusion studies, La3+ significantly increased Mn influx 
more than 4-fold. A literature search did not reveal any other reports of La3+ 
increasing transporter or carrier activity. There was no effect on brain Ca influx in the 
present studies, suggesting La3+ did not block Ca influx. Furthermore, the results 
suggest that the La3+ effect on Mn influx at the BBB is independent of Ca. In bBMEC 
studies, La3+ did not significantly affect Mn or Ca uptake. While rat studies indicated 
that La3+ increases Mn, but not brain Ca influx, bBMEC studies suggested a non-
significant decrease in Mn and Ca uptake. The results suggest that Mn uptake at the 
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BBB also occurs through one or more Ca-independent processes, since La3+ 
increases Mn uptake without affecting Ca. 
 
Another explanation for the unexpected increase in Mn uptake by La3+ is trans-
stimulation of the endothelial cells. This process occurs when a substrate on one 
side of the cell membrane increases substrate transfer from the other side. trans-
Stimulation has been shown to play a role in the uptake of glucose into bovine 
mammary epithelial cells (Xiao and Cant, 2003), agmatine through the human 
extraneuronal monoamine transporter (Grundemann et al., 2003) and sorbitol into a 
renal medullary cell line (Schuttert et al., 2002). 54Mn efflux from astrocytes was 
trans-stimulated by 55Mn in the media (Aschner, et al., 1992). La3+ may enter cells 
rapidly and then cause greater Mn influx through trans-stimulation. 
 
In bBMEC studies, Mn entry was inhibited by vanadate (0.003 and 1 mM). Despite 
indications in bBMECs, addition of 1 or 10 mM vanadate to 54Mn in the in situ brain 
perfusate did not decrease brain Mn influx. Ca-ATPases are found on both the 
luminal and abluminal surface of brain endothelial cells, which may confound our 
interpretation of the results (Manoonkitiwongsa et al., 2000). Mn distribution into 
endothelial and brain cell plus extracellular fluid fractions, as measured with the 
capillary depletion method, was unaltered by vanadate, suggesting neither brain Mn 
influx nor efflux are mediated by Ca-ATPase. Although vanadate inhibited Mn uptake 
into bBMECs, it did not inhibit Mn influx across the BBB.  p-Hydroxyhippuric acid, a 
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relatively selective Ca-ATPase inhibitor, also did not inhibit brain Mn influx, providing 
further evidence against a role for Ca-ATPase.  
 
Studies with inhibitors of voltage-gated Ca channels also failed to implicate these 
channels in brain Mn uptake. This is not surprising, as endothelial cells are not 
considered excitable and would not be expected to use voltage-gated channels. On 
the other hand, it was recently determined that brain endothelial cells do express L-
type Ca channels (Bossu et al., 1992). Verapamil did not significantly decrease Mn 
or Ca influx. In a similar study in the absence of 45Ca, verapamil and amiloride failed 
to alter brain 54Mn influx.  These results suggest brain Mn entry is not likely to occur 
through voltage-gated Ca channels under physiological conditions.   
 
Thapsigargin and CPA significantly increased Mn uptake, 2.5- and 2.6-fold, 
respectively, consistent with the hypothesis that SOCs play a role. Thapsigargin did 
not significantly increase Ca uptake (P=0.07) despite the 1.4-10-fold increase in Ca 
uptake. Earlier reports implicated SOCs in the influx of metals across the BBB. Lead 
uptake into bBMECs was increased by 1.7- and 2.1-fold following treatment with 
CPA or thapsigargin, respectively (Kerper and Hinkle, 1997b). The pH dependence 
of Mn uptake is also consistent with a role for SOCs in Mn influx at the BBB. Store-
operated Ca influx was inhibited by low extracellular pH in human microglia (Khoo et 
al., 2001). These results suggest that brain Mn uptake occurs through the SOCs. 
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In summary, there are at least two transporters for brain Mn influx. Mn entry into 
brain occurs through at least one pathway that does not have a high affinity for Ca, 
as evidenced with the La3+ data. Mn influx also is likely to occur through a Ni-
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  Table 1. Characteristics of 54Mn2+ uptake into bBMECs  
Treatment 
Mn uptake 
(% control ± SEM) n 
Control (122 mM Na+) 100 ± 7  6 
  61 mM Na+, 61 mM  choline 97 ± 18  3 
  122 mM% Choline (no Na+) 160 ± 6*  5 
  122 mM Li+ (no Na+) 90 ± 9  4 
    
Control (vehicle) 100 ± 10  3 
   Ouabain 129 ± 15  3 
    
Control (vehicle) 100 ± 6  8 
  2,4-Dinitrophenol 102 ± 5  6 
  Azide 124 ± 4  3 
  2-Deoxyglucose 84 ± 8  4 
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Table 2. Mn and Ca uptake into bBMECs in the presence of Ca transporter        
inhibitors   
Treatment 
Ca uptake 
(% control ± SEM) 
Mn uptake 
(% control ± SEM) N 
Control  100 ± 18 5 
   No Ca2+  170 ± 29* 4 
    
Control  100 ± 5 4 
   Vanadate (0.003 µM) 64 ± 3* 3 
   Vanadate (1 mM) 53 ± 4* 3 
   Vanadate pretreatment (1 mM) 39 ± 4* 3 
    
Control 100 ± 17 100 ± 8 4 
   La3+ 58 ± 25* 64 ± 24 4 
   Ni2+ 15 ± 15* 12 ± 3* 3 
   Verapamil 54 ± 3 81 ± 2 3 
    
Control (vehicle) 100 ± 30 100 ± 13 3 
   CPA 418 ± 98* 265 ± 48* 4 
   Thapsigargin 415 ± 212 252 ± 23* 4 
   * =significantly different from control. 
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Figure 1. Mn uptake into bBMECs correlates inversely with proton concentration.  
Values are mean percent of control (pH 7.4) uptake ± SEM for 3-6 experiments, 
following 30 minute incubation. Inset: Time dependent uptake of Mn at pH 6.4 
versus 7.4 is shown. * denotes a significant difference from control 
 
Figure 2. The Arrhenius plot shows temperature-dependent Mn uptake into 
bBMECs. Values shown are the natural log of the mean ± SEM of uptake (pmol/30 
min/mg). 
 
Figure 3. Mn influx correlates negatively with Ca concentration following in situ 
perfusion, but Mn concentration has no effect on Ca influx. A) Mn and B) Ca influx 
values into brain are shown (mean ± SEM of 4-5 animals).   
 
Figure 4. La increased Mn influx into rat brain. Values shown are mean ± SEM 
(n=5). The Y-axis in panel A is different from previous Mn influx graphs.  
 
Figure 5. Ni did not decrease Mn (A) influx into rat brain across the BBB. Values 
shown are mean ± SEM (n=5). * significantly different from control 
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